GlassScriptPhysician profile
Catalin Toma
NPI 1356441497
$119,930.59
in general payments reported to CMS, 2019-2025
30 companies · $23K in 2025
The $23K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,823 · 2020: $1,675 · 2021: $5,743 · 2022: $18K · 2023: $26K · 2024: $38K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $67K · Food and Beverage: $13K · Consulting Fee: $4,800 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $67,191.78 |
| Food and Beverage | $13,111.40 |
| Consulting Fee | $4,800.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $54,138.06 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $19,799.71 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Medtronic, INC. | $16,652.87 | 2021-2025 | Corevalve Evolut R |
| Neptune Medical INC. | $5,280.20 | 2023-2024 | |
| Abbott Laboratories | $4,691.52 | 2019-2025 | Navitor, Portico, Amplatzer Amulet |
| Shockwave Medical, INC | $4,637.24 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $4,050.56 | 2019-2025 | Avvigo Guidance System, Watchman Flx, General - Therapies |
| Ancora Heart, INC. | $2,989.88 | 2023 | Accucinch |
| Philips North America LLC | $2,667.38 | 2019-2024 | (P88) Igt Devices Fm |
| Abiomed | $2,237.26 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $1,182.97 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Livanova USA, INC. | $193.74 | 2019-2025 | Tandemheart |
| Amgen INC. | $175.38 | 2023-2025 | Repatha, Repatha |
| Recor Medical INC | $161.82 | 2024 | Paradise Renal Denervation System |
| Cardiva Medical, INC. | $134.65 | 2022-2024 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $130.89 | 2023-2025 | Camzyos, Eliquis |
| Terumo Medical Corporation | $129.12 | 2024 | Metacross Otw, Optitorque |
| W. L. Gore & Associates, INC. | $127.65 | 2019-2025 | Gore Cardioform Septal Occluder |
| Teleflex LLC | $91.85 | 2025 | Orsiro Mission |
| Vifor Pharma, INC. | $87.74 | 2022-2023 | Korsuva, Veltassa |
| Cardiovascular Systems INC. | $81.29 | 2019-2023 | Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.71 | 2024-2025 | Jardiance |
| Asahi Intecc USA, INC. | $49.26 | 2019 | |
| Heartflow, INC. | $38.74 | 2023-2025 | Ffrct |
| Biotronik INC. | $37.03 | 2022 | |
| Endotronix, INC. | $27.85 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Merck Sharp & Dohme LLC | $24.45 | 2025 | Winrevair |
| Kestra Medical Technology Services, INC. | $21.28 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $16.72 | 2019 | |
| Pfizer INC. | $14.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catalin Toma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.